Epi-off riboflavin with vitamin E TPGS (Ribocross®) cross-linking: one-year outcome
International Ophthalmology · 2024
DOI: 10.1007/s10792-024-03354-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Ophthalmology, 2024. Verfasst von Pietro Paolo Saba und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy. Hauptthemen laut MEDLINE: Riboflavin, Keratoconus, Cross-Linking Reagents, Vitamin E. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To assess the short and mid-term outcomes of epithelium-off (epi-off) corneal collagen cross-linking using Riboflavin with Vitamin E TPGS (Epi-off Ribocross® CXL) for progressive keratoconus (KC). DESIGN: Retrospective, single-center non-comparative interventional study. METHODS: Patients with progressive keratoconus who underwent CXL using (Epi-off Ribocross® CXL) from May 2021 to May 2022 who completed at least 12 months of follow-up in Humanitas Clinical and Research Center, Rozzano, Milan, Italy. Corrected distance visual acuity with spectable (CDVA), tomographic parameters (Belin ABCD) and topographic parameters were evaluated at baseline and at last follow up. RESULTS: Twenty eyes of twenty patients fulfilled inclusion criteria. CDVA remained stable at last follow up (0.88 ± 0.19 from 0.83 ± 0.21, p = 0.45) with a significant reduction in cylinder (1.97 ± 1.69 from 2.78 ± 2.19, p = 0.03). Kmax significantly improved from 53.18D ± 6.32 to 50.96 ± 5.3D (p = 0.005). At the last follow up, no case of progression was noted. CONCLUSIONS: Epi-off Ribocross® CXL proved to be a safe treatment for progressive KC, with a stabilization of all cases at the one year follow up. Further studies are needed to confirm long-term stability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy.
- Department of Ophthalmology, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy. Luca.pagano91@hotmail.it.
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Pieve Emanuele, Milan, Italy.
- Department of Ophthalmology, Humanitas San Pio X Hospital, Milan, Italy.
Zitieren
APA
Saba, P. P., Feo, A., Pagano, L., Vinciguerra, P., & Vinciguerra, R. (2024). Epi-off riboflavin with vitamin E TPGS (Ribocross®) cross-linking: one-year outcome. International Ophthalmology. https://doi.org/10.1007/s10792-024-03354-9
Vancouver
Saba PP, Feo A, Pagano L, Vinciguerra P, Vinciguerra R. Epi-off riboflavin with vitamin E TPGS (Ribocross®) cross-linking: one-year outcome. International Ophthalmology. 2024. doi:10.1007/s10792-024-03354-9
BibTeX
@article{Saba2024,
author = {Saba, Pietro Paolo and Feo, Alessandro and Pagano, Luca and Vinciguerra, Paolo and Vinciguerra, Riccardo},
title = {Epi-off riboflavin with vitamin E TPGS (Ribocross®) cross-linking: one-year outcome},
journal = {International Ophthalmology},
year = {2024},
doi = {10.1007/s10792-024-03354-9}
}
EUVIMED